These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6223588

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.
    Toge T, Tanada M, Yajima K, Kohno H, Itagaki E, Hattori T.
    Clin Exp Immunol; 1983 Oct; 54(1):80-6. PubMed ID: 6225584
    [Abstract] [Full Text] [Related]

  • 4. Increased number of suppressor T-cells and impaired IL-2 mediated T-cell function in peripheral blood of gastric cancer patients.
    Tsubono M, Nio Y, Shiraishi T, Morimoto H, Tseng CC, Kawabata K, Masai Y, Fukumoto M, Tobe T.
    J Clin Lab Immunol; 1990 Nov; 33(3):107-15. PubMed ID: 1966999
    [Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance].
    Ogoshi K, Kondoh Y, Nakasaki H, Tajima T, Mitomi T.
    Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640
    [Abstract] [Full Text] [Related]

  • 6. [Significance of human Tr cell in gastric cancer --with special reference to suppressor cell activity].
    Itagaki E, Toge T, Tanada M, Hamamoto S, Seto Y, Kohno H, Hattori T.
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):123-9. PubMed ID: 6230053
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study on serum immunosuppressive factors in gastric cancer patients--with special reference to preoperative IAP values and the influence of surgical stress].
    Yokoyama Y, Saji S, Niwa H, Takao H, Kida H, Umemoto T, Kawata R, Sakata K, Tanaka S.
    Gan No Rinsho; 1985 Aug; 31(10):1275-80. PubMed ID: 2414478
    [Abstract] [Full Text] [Related]

  • 8. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
    Kageyama T, Oyabu H, Ohshiba S.
    Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269
    [Abstract] [Full Text] [Related]

  • 9. Induction of impaired activation of lymphocytes by suppressive factor in Crohn's disease patients.
    Watanabe M, Tsuru S, Aiso S, Hibi T, Yoshida T, Asakura H, Zinnaka Y, Tsuchiya M.
    J Clin Lab Immunol; 1984 May; 14(1):29-34. PubMed ID: 6748044
    [Abstract] [Full Text] [Related]

  • 10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S, Cunningham-Rundles S.
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of measurement of immunosuppressive acidic protein (IAP) in lung cancer].
    Kondo H, Seno N, Matsuo S, Otagaki S, Matsuki T, Hatayama T.
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2163-70. PubMed ID: 6625623
    [Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
    Takada M.
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of immunosuppressive acidic protein (IAP) in various disease states and their clinical significance].
    Kikuchi S.
    Nihon Geka Gakkai Zasshi; 1984 Apr; 85(4):283-99. PubMed ID: 6749105
    [Abstract] [Full Text] [Related]

  • 14. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in connection with its high level in tumor-bearing mice.
    Shibata Y, Tamura K, Ishida N.
    Cancer Res; 1983 Jun; 43(6):2889-96. PubMed ID: 6221795
    [Abstract] [Full Text] [Related]

  • 15. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
    Nishio S, Ozaki Y, Wada S, Kawakita J, Maekawa M.
    Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
    [Abstract] [Full Text] [Related]

  • 16. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
    Yamaguchi Y, Hihara J, Hironaka K, Ohshita A, Okita R, Okawaki M, Matsuura K, Nagamine I, Ikeda T, Ohara M, Hamai Y.
    Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
    [Abstract] [Full Text] [Related]

  • 17. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
    Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, Yokoe T, Hiro J, Ojima E, Tanaka K, Kusunoki M.
    J Surg Oncol; 2008 Apr 01; 97(5):404-8. PubMed ID: 18181167
    [Abstract] [Full Text] [Related]

  • 18. [Activity of non-specific T-suppressors regulating the proliferation of B- and T-lymphocytes in patients with fibroadenomatosis, breast cancer and stomach cancer].
    Grinevich IuA, Drannik GN, Nikol'skiĭ IS, Kalinina NA, Litvishchenko EI.
    Vopr Onkol; 1984 Apr 01; 30(12):23-7. PubMed ID: 6240157
    [Abstract] [Full Text] [Related]

  • 19. [Immunological significance of splenectomy in gastric cancer surgery. Production of immunosuppressive factor in the spleen].
    Kanayama H, Oda M, Karino T, Yamane T, Hamazoe R, Osaki Y, Shimizu N, Maeta M, Koga S.
    Nihon Geka Gakkai Zasshi; 1983 Sep 01; 84(9):952-6. PubMed ID: 6676666
    [Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive factor in the sera of patients with stomach cancer--with special reference to IAP (immunosuppressive acidic protein)].
    Shimizu N, Izumi A, Ozaki Y, Kanayama H, Maeda M, Koga S.
    Gan No Rinsho; 1982 Sep 01; 28(2):125-8. PubMed ID: 7182557
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.